Treatment of infections due to resistant organisms

British Medical Bulletin

Volumn 61, Issue , 2002, Pages 231-245

  Heath, P T ^a   Breathnach, A S ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; LINEZOLID; MACROLIDE; NAFCILLIN; OXACILLIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL PNEUMONIA; CHRONIC LUNG DISEASE; DRUG EXPOSURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNITED KINGDOM;

BACTERIAL VACCINES; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNOSUPPRESSION; INFANT; INFANT, NEWBORN; PNEUMONIA, PNEUMOCOCCAL; TRAVEL;

EID: 0036248505     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/61.1.231     Document Type: Review

References (22)

1. Nosocomial infections in pediatric intensive care units in the United States
2. Nosocomial Legionnaire's disease in a children's hospital
3. Antimicrobial susceptibility of Haemophilus influenzae in the respiratory tracts of patients with cystic fibrosis
4. Microbiologic data overview of Italian cystic fibrosis patients
5. Microbiology of sputum from patients at cystic fibrosis centers in the United States
6. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States
7. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae
8. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease
9. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae
10. Failure of treatment of pneumonia associated with highly resistant pneumococci in a child
11. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)
12. Resistance patterns of lower respiratory tract pathogens in Europe
13. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors
14. Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know
15. Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns
16. Progressive respiratory distress in an infant treated for presumed pertussis
17. Control and prevention of tuberculosis in the United Kingdom: Code of practice 2000
18. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations 1998
19. Rifampin preventive therapy for tuberculosis in Boston's homeless
20. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria
21. Antimicrobial susceptibility of Pseudomonas aeruginosa: Results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test
22. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis